References
- Eskazan AE, Erdogan I, Berk S, et al. Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: Tyrosine kinase inhibitors? Donor lymphocyte infusions? or Both? Leuk Lympoma 2015 Mar 9. [Epub ahead of print]
- Zeidner JF, Zahurak M, Rosner GL, et al. The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leuk Lymphoma 2015;56:128–134.
- Venepalli N, Rezvani K, Mielke S, et al. Role of allo-SCT for CML in2010. Bone Marrow Transplant 2010; 45:1579–1586.
- Egan DN, Beppu L, Radich JP. Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation. Biol Blood Marrow Transplant 2015;21:184–189.